VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) announces that pursuant to the Company's stock option plan, 7,151,055 incentive stock options exercisable at $0.19 per share for a period of five years have been granted to directors, officers, employees and consultants of the Company. This option grant is subject to TSX Venture exchange approval About Atico Mining Corporation Atico is a growth-oriented Company, focus ...

NEW YORK and TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, previously issued a press release announcing that it had authorized a one-time payment to its stockholders in the amount of $0.13 per share of common stock. For U.S. federal tax purposes, this payment to stockholders will be deemed to be a distribution. The Company’s press release incorrectly stated that ...

PresentationOperator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ContextLogic's Third Quarter 2025 Earnings Conference Call. [Operator Instructions]. And there will not be a question and answer session at the conclusion of today's call. However, a recording and transcript will be made available online, and management will make themselves available to the investor community over the coming weeks. Except for historical information, the matters discussed during this call ma ...

季度分红声明 - 公司宣布季度现金分红为每普通单位0.830美元，由0.775美元的基本金额和0.055美元的变动金额构成 [1] - 分红派发对象为截至2025年11月7日登记在册的单位持有人，并计划于2025年11月14日支付 [1] - 公司同时宣布了向其普通合伙人进行的相关分红派发 [1] 税务处理信息 - 支付给外国人的季度现金分红部分通常需缴纳美国预扣所得税 [2] - 公司100%支付给外国投资者的分红均被视为与美国贸易或业务有效相关的收入，需根据相关法规进行联邦所得税预扣 [3] - 就特定法规而言，公司支付给外国投资者的全部分红均超过累计净收入 [3] 公司业务概况 - 公司拥有位于路易斯安那州的Sabine Pass液化天然气接收站，其天然气液化设施的总生产能力超过每年3000万吨液化天然气 [4] - Sabine Pass液化天然气接收站还拥有运营中的再气化设施，包括五个液化天然气储罐、气化器和三个海运泊位 [4] - 公司还拥有Creole Trail管道，该管道将Sabine Pass液化天然气接收站与多个大型州际和州内管道连接起来 [4] 其他相关信息 - 公司建议投资者查阅其网站以及提交给美国证券交易委员会的截至2025年6月30日的季度报表10-Q以获取更多信息 [5] - 新闻稿中包含了关于公司财务和运营指引、业务战略以及季度分红能力等方面的前瞻性陈述 [6]

PETAH TIKVA, Israel, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its third quarter 2025 financial results on Wednesday, November 12, 2025. Conference Call and WebcastFollowing the release, Adi Sfadia, Chief Executive Officer, and Gil Benyamini, Chief Financial Officer, will discuss Gilat’s third quarter 2025 results and business achievements and ...

公司上市与交易信息 - 公司普通股于2025年10月8日在纳斯达克资本市场开始交易 股票代码为“TTRX” [1] - 公司的S-1注册声明已于2025年9月30日获得美国证券交易委员会（SEC）宣布生效 [1] - 公司创始人兼首席执行官Bradley Burnam将于美国东部时间2025年10月8日下午4点敲响纳斯达克闭市钟 [1] 公司业务与产品管线 - 公司是一家临床阶段生物技术公司 专注于开发下一代皮肤病学、伤口护理和抗感染疗法 [1] - 公司已为其专有的伤口和皮肤病学配方获得三项美国FDA批准 [2] - 公司正在推进针对湿疹和甲癣的后期临床项目 [2] - 公司致力于全球健康计划 开发用于服务全球服务不足地区的热稳定疫苗递送技术 [2] 公司合作与联系方式 - Clear Street LLC担任公司的财务顾问 Davis Polk and Wardwell担任法律顾问 [1] - 媒体联系邮箱为media@TurnTherapeuticscom 投资者关系联系邮箱为Investors@TurnTherapeuticscom [4]

COLUMBUS, Ga.--(BUSINESS WIRE)--Synovus Financial Corp. (NYSE: SNV) Chairman, CEO and President Kevin Blair will participate in a joint fireside chat with Pinnacle Financial Partners President and CEO Terry Turner at the BancAnalysts Association of Boston Conference on Thursday, Nov. 6, 2025, at 2:15 p.m. ET. Mr. Blair and Mr. Turner are expected to discuss the pending merger between Pinnacle Financial Partners and Synovus Financial Corp. This press release contains statements that constitute "forward-looki ...

Individual and institutional investors, advisors, and analysts are invited to attendSINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company’s management team, including Chief Executive Officer, D ...

MIAMI, Oct. 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) announced that it will report results for the fourth fiscal quarter ended September 30, 2025 on Monday, November 24, 2025 after the close of the financial markets. The Company will also host a conference call at 9:00 a.m. (Eastern Time) on Tuesday, November 25, 2025 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing toll- ...

财务报告发布安排 - 公司宣布推迟发布2025年上半年度财务报告 [1] - 原定发布日期为2025年9月30日 [1] - 新的最晚发布日期确认为2025年10月10日 [1][2] - 延迟原因是为确保审计师有充足时间完成审计工作 [1] 公司业务概况 - 公司是一家成立于2001年的制药企业 [3] - 公司专注于蛋白激酶抑制剂的研发、开发及商业化 [3] - 研发项目聚焦于存在高度未满足医疗需求的疾病领域 [3] - 主要候选药物马赛替尼已注册用于兽医学 [4] - 马赛替尼在人类医学中正被开发用于肿瘤学、神经系统疾病、炎症性疾病及病毒性疾病领域 [4] - 公司总部位于法国巴黎 在巴黎泛欧交易所上市 [4]